Skip to content
Riskpilot
← Back to search
Sign in
Get full access
OSLO PHARMA INVEST AS
AS
Active
Org 992915927
Steinliveien 1A, 1185
Oslo
Rental and operating of own or leased real estate
· NACE 6820
Est. 2008
0 employees
Watchlist
Share
Norway
/
Companies
/
Rental and operating of own or leased real estate
/
OSLO PHARMA INVEST AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
2M
3M
5M
7M
3M
2020
5M
2021
5M
2022
6M
2023
6M
2024
EBITDA
NOK millions
0M
1M
3M
4M
6M
2M
2020
4M
2021
4M
2022
4M
2023
5M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
3 096
4 543
5 064
5 513
5 876
Staff expenses
−0
−0
−0
−0
−0
EBITDA
2 038
3 557
4 248
4 271
4 815
Depreciation & amort.
−4
−4
−4
−3
−0
EBIT
2 034
3 553
4 244
4 268
4 815
Net financials
−1 820
−2 121
19 639
−4 169
3 208
Profit before tax
214
1 432
23 882
99
8 023
Tax
47
315
230
−1
1 126
Net profit
167
1 117
23 652
100
6 897
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
107 169
116 233
143 832
118 566
137 378
Equity
18 826
19 943
43 596
43 695
50 592
Long-term debt
71 779
75 449
75 498
73 095
84 511
Short-term debt
16 563
20 841
24 739
1 776
2 275
Total debt
88 342
96 290
100 237
74 871
86 786
Financial ratios
5-year trend
EBITDA margin
82.0%
This company
15.8%
Market median
+419% vs market
2020
2024
Equity ratio
36.8%
This company
38.2%
Market median
+4% vs market
2020
2024
Return on equity
13.6%
This company
18.4%
Market median
+26% vs market
2020
2024
Net profit margin
117.4%
This company
8.1%
Market median
+1349% vs market
2020
2024
Asset turnover
0.04×
This company
1.12×
Market median
-96% vs market
2020
2024
Debt / equity
1.72×
This company
0.62×
Market median
-177% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on OSLO PHARMA INVEST AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
